WallStSmart
ARDT

Ardent Health Partners, Inc.

NYSE: ARDT · HEALTHCARE · MEDICAL CARE FACILITIES

$9.95
+0.93% today

Updated 2026-06-05

Market cap
$1.32B
P/E ratio
9.72
P/S ratio
0.21x
EPS (TTM)
$0.95
Dividend yield
52W range
$8 – $15
Volume
0.4M

Ardent Health Partners, Inc. (ARDT) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201520162017201820212022202320242025
Total assets$1.09B$2.37B$2.75B$4.86B$5.10B$4.96B$5.29B
Cash & equivalents$92.61M$71.96M$59.66M$456.12M$437.58M$556.78M$709.60M
Current assets$471.15M$736.42M$860.42M$1.41B$1.62B$1.83B$2.06B
Total liabilities$689.36M$1.61B$2.03B$3.81B$4.02B$3.43B$3.61B
Current liabilities$328.14M$507.35M$624.83M$808.60M$994.10M$945.42M$1.05B
Long-term debt$1.16B$1.17B$1.09B$1.08B
Shareholder equity$266.54M$377.72M$331.64M$639.05M$670.90M$1.13B$1.69B
Retained earnings$11.51M$-24.14M$-167.16M$101.55M$155.45M$365.80M$501.61M
Accounts receivable$261.04M$453.85M$529.12M$611.96M$785.76M$743.03M$686.10M
Inventory$47.09M$84.16M$84.81M$107.15M$105.48M$115.09M$118.59M
Goodwill$244.49M$818.19M$822.03M$844.70M$844.70M$852.08M$879.45M

Frequently asked questions

What is Ardent Health Partners, Inc.'s revenue?

Ardent Health Partners, Inc.'s trailing twelve-month revenue is $6.43B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ARDT?

In its most recent fiscal year, ARDT ran a gross margin of 97.54%, an operating margin of 5.15%, and a net margin of 2.15%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ARDT generate?

ARDT produced $258.61M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ARDT's balance sheet healthy?

ARDT holds $709.60M in cash and equivalents against $1.08B in long-term debt, on $1.69B of shareholder equity. That debt is best read against the cash flow the business throws off each year.